Pelvic inflammatory disease: review of treatment options

H B Peterson1, E I Galaid, J M Zenilman

  • 1U.S. Department of Health and Human Services, Atlanta, Georgia.

Insights

Treatment guidelines for pelvic inflammatory disease (PID) are evolving due to incomplete understanding and antibiotic resistance. Current recommendations favor broad-spectrum antibiotic therapy for both inpatient and ambulatory cases.

Area of Science:

  • Infectious Diseases
  • Gynecology
  • Microbiology

Background:

  • Pelvic inflammatory disease (PID) treatment decisions are complex due to incomplete understanding of the syndrome.
  • Limited data on laparoscopic diagnosis and cure of PID hinder interpretation of therapy outcomes.
  • Increasing resistance of Neisseria gonorrhoeae to penicillin impacts treatment strategies.

Purpose of the Study:

  • To review and update antibiotic therapy recommendations for pelvic inflammatory disease (PID).
  • To evaluate the effectiveness of current and newer treatment regimens based on available data.
  • To address challenges in PID management, including diagnostic limitations and evolving microbial resistance.

Main Methods:

  • Review of validation studies for recommended antibiotic regimens.
  • Analysis of data from the 1985 and 1989 Centers for Disease Control (CDC) sexually transmitted diseases (STDs) treatment guidelines.
  • Assessment of clinical cure rates for cefoxitin/doxycycline and clindamycin/aminoglycoside regimens.

Main Results:

  • Cefoxitin/doxycycline and clindamycin/aminoglycoside regimens show consistently high clinical cure rates for PID.
  • Empiric, broad-spectrum antibiotic therapy remains the preferred treatment approach.
  • 1989 inpatient therapy recommendations are similar to 1985, but ambulatory management recommendations have changed significantly.

Conclusions:

  • Current antibiotic regimens demonstrate high efficacy in treating pelvic inflammatory disease (PID).
  • Empiric broad-spectrum therapy is crucial for effective PID management.
  • Adjustments in ambulatory PID treatment are necessary due to Neisseria gonorrhoeae penicillin resistance.

Related Concept Videos

Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...